Cresco Labs posts Q4 revenue of $175.91M, beating estimates. The company secured a Tier 3 cultivation license in Kentucky, expanding its market presence.

Investors might want to bet on Cresco Labs Inc. (CRLBF), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

Q4 2024 Earnings Conference Call March 12, 2025 8:30 AM ETCompany ParticipantsTJ Cole - Senior Vice President, ...

About Cresco Labs Inc. Cresco Labs’ mission is to normalize and professionalize the cannabis industry through a CPG approach to building national brands and a customer-focused retail experience ...

Stock analysts at Roth Capital issued their Q1 2025 earnings per share (EPS) estimates for Cresco Labs in a research report ...

Cresco Labs Inc. (CRLBF) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's ...

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“ Cresco Labs ” or the “ Company ”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the ...

Cresco Labs Inc. (CRLBF) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.01 per share a year ago. These figures are ...

Shares of Cresco Labs Inc. (OTCMKTS:CRLBF – Get Free Report) traded down 0.6% during trading on Monday .The stock traded as low as $0.86 and last traded at $0.89. 313,011 shares changed hands ...

Debt Reduction: Retired $40 million of the 2026 note in Q4. Cresco Labs Inc (CRLBF) generated $724 million in revenue for 2024, maintaining adjusted gross profit dollars flat despite a slight year ...